Relationship between HbA1c and hypoglycaemia in patients with type 2 diabetes treated with different insulin regimens in combination with metformin
✍ Scribed by John Y. C. Chan; Malgorzata Leyk; Brian M. Frier; Meng H. Tan
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 142 KB
- Volume
- 25
- Category
- Article
- ISSN
- 1520-7552
- DOI
- 10.1002/dmrr.929
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## Abstract ## Background Several studies have shown an increase of mortality in diabetic patients treated with combinations of sulphonylureas and biguanides. Comparisons between different insulin secretagogues in combination with metformin with respect to all‐cause mortality have not been reporte
Elderly insulin-treated diabetic patients have a high risk of severe hypoglycaemia, yet their hypoglycaemic symptom profile has attracted little research. In this study, the frequency and intensity of symptoms of hypoglycaemia were recorded using a validated questionnaire in 132 insulin-treated diab
## Background: The plasma cell differentiation antigen (pc-1) is an inhibitor of insulin receptor tyrosine kinase activity, and has been implicated in the pathogenesis of insulin resistance in type 2 diabetes. metformin increases peripheral insulin sensitivity and, therefore, we have studied the ef
## Abstract ## Background Severe hypoglycaemia is a potentially life‐threatening condition. The aim of the present study was to compare the frequency of severe hypoglycaemia in patients with type 2 diabetes treated with glimepiride versus glibenclamide. ## Methods This prospective, population‐ba